本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMV Pharmaceuticals

1.45
-0.0100-0.68%
成交量:1.81萬
成交額:2.63萬
市值:1.09億
市盈率:-1.03
高:1.45
開:1.45
低:1.45
收:1.46
52周最高:1.88
52周最低:1.02
股本:7,551.31萬
流通股本:6,838.37萬
量比:1.81
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
淨資產收益率:-70.93%
總資產收益率:-42.39%
市淨率:1.53
市盈率(LYR):-0.98

資料載入中...

2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/28

重要事件披露

8-K - Current report
2023/03/01

重要事件披露

8-K - Current report
2023/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/04

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals